Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and in vitro evaluation.

Doxorubicin (Dox) was conjugated onto a biodegradable block copolymer methoxy-poly(ethylene glycol)-block-poly(lactide-co-2,2-dihydroxymethylpropylene carbonate (mPEG-b-P(LA-co-DHP)) via a carbamate linkage and an acid-labile hydrazone linkage, respectively. Mutifunctional mixed micelles consisting of Dox-containing copolymer mPEG-b-P(LA-co-DHP/Dox) and folic acid-containing copolymer mPEG-b-P(LA-co-DHP/FA) were successfully prepared by coassembling the two component copolymers. The mixed micelles had well-defined core shell structure and their diameters were in the range of 70-100 nm. Both Dox-conjugates (via carbamate or hydrazone linkage) showed pH-dependent release behavior, and the micelles with hydrazone linkage showed more pH-sensitivity compared to those with carbamate linkage. The in vitro cell uptake experiment by CLSM and flow cytometry showed preferential internalization of FA-containing micelles by human ovarian cancer cell line SKOV-3 than that without FA. Flow cytometric analysis was conducted to reveal the enhanced cell apoptosis caused by the FA-containing micelles. These results suggested that these micelles containing both chemotherapeutic and targeting ligand could be a promising nanocarrier for targeting the drugs to cancer cells and releasing the drug molecules inside the cancer cells.

[1]  H. Ringsdorf,et al.  Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .

[2]  T. Okano,et al.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.

[3]  A. Kabanov,et al.  Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.

[4]  J. Kopeček,et al.  HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Kabanov,et al.  Novel drug delivery systems based on the complexes of block ionomers and surfactants of opposite charge , 1999 .

[6]  T. Okano,et al.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[7]  K. Ulbrich,et al.  Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[8]  T. Park,et al.  Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[9]  K. Ulbrich,et al.  Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation , 2004, Journal of drug targeting.

[10]  K. Brown,et al.  Cell-specific delivery of a chemotherapeutic to lung cancer cells. , 2004, Journal of the American Chemical Society.

[11]  Tae Gwan Park,et al.  Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  G. Hsiue,et al.  Polymeric micelles with a pH-responsive structure as intracellular drug carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Theresa M. Allen,et al.  Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors , 2005, Clinical Cancer Research.

[14]  K. Ulbrich,et al.  Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Kazunori Kataoka,et al.  Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. , 2005, Bioconjugate chemistry.

[16]  Jayant Khandare,et al.  Polymer-drug conjugates: Progress in polymeric prodrugs , 2006 .

[17]  Kazunori Kataoka,et al.  Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. , 2006, Pharmacology & therapeutics.

[18]  A. Chilkoti,et al.  Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Subbu S. Venkatraman,et al.  Block Copolymer ‘Stealth’ Nanoparticles for Chemotherapy: Interactions with Blood Cells In Vitro , 2008 .

[20]  K. Ulbrich,et al.  Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Rassoul Dinarvand,et al.  Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate , 2008 .

[22]  F. Greco,et al.  Polymer-drug conjugates: current status and future trends. , 2008, Frontiers in bioscience : a journal and virtual library.

[23]  Xuesi Chen,et al.  Biodegradable amphiphilic block copolymers bearing protected hydroxyl groups: synthesis and characterization. , 2008, Biomacromolecules.

[24]  X. Shuai,et al.  Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs , 2008, Biomedical microdevices.

[25]  K. Ulbrich,et al.  Biological evaluation of polymeric micelles with covalently bound doxorubicin. , 2009, Bioconjugate chemistry.

[26]  R. Duncan,et al.  Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker. , 2009, Macromolecular bioscience.

[27]  K. Ulbrich,et al.  HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[28]  B. Říhová Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates. , 2009, Advanced drug delivery reviews.

[29]  A. David,et al.  E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells. , 2009, Biomaterials.

[30]  X. Jing,et al.  Folate-conjugated micelles and their folate-receptor-mediated endocytosis. , 2009, Macromolecular bioscience.

[31]  C. van Nostrum,et al.  Micelles based on HPMA copolymers. , 2010, Advanced drug delivery reviews.